Clinical utility of existing and second-generation interferon-γ release assays for diagnostic evaluation of tuberculosis: an observational cohort study by Whitworth, H, Badhan, A, Boakye, A, Takwoingi, Y, Rees-Roberts, M, Partlett, C, Lambie, H, Innes, J, Cooke, G, Lipman, M, Conlon, C, Macallan, D, Chua, F, Post, F, Wiselka, M, Woltmann, G, Deeks, J, Kon, O, Lalvani, A

Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C by Cooke, GS, Pett, S, McCabe, L, Jones, C, Gilson, R, Verma, S, Ryder, SD, Collier, JD, Barclay, ST, Ala, A, Bhagani, S, Nelson, M, Ch'Ng, C, Stone, B, Wiselka, M, Forton, D, McPherson, S, Halford, R, Nguyen, D, Smith, D, Ansari, A, Dennis, E, Hudson, F, Barnes, EJ, Walker, AS

Clinical utility of existing and second-generation interferon-γ release assays for diagnostic evaluation of tuberculosis: an observational cohort study by Whitworth, H, Badhan, A, Boakye, A, Takwoingi, Y, Rees-Roberts, M, Partlett, C, Lambie, H, Innes, J, Cooke, G, Lipman, M, Conlon, C, Macallan, D, Chua, F, Post, F, Wiselka, M, Woltmann, G, Deeks, J, Kon, O, Lalvani, A, Interferon-γ Release Assays for Diagnostic Evaluation of Active Tuberculosis study group

Variable short duration treatment versus standard treatment, with and without adjunctive ribavirin, for chronic hepatitis C: the STOP-HCV-1 non-inferiority, factorial RCT by Cooke, GS, Pett, SL, McCabe, L, Jones, C, Gilson, R, Verma, S, Ryder, SD, Collier, JD, Barclay, ST, Ala, A, Bhagani, S, Nelson, M, Ch'Ng, CL, Stone, B, Wiselka, M, Forton, D, McPherson, S, Halford, R, Nguygen, D, Smith, D, Ansari, MA, Ainscough, H, Dennis, E, Hudson, F, Barnes, EJ, Walker, AS

Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial by Horby, PW, Campbell, M, Spata, E, Emberson, JR, Staplin, N, Pessoa-Amorim, G, Peto, L, Wiselka, M, Wiffen, L, Tiberi, S, Caplin, B, Wroe, C, Green, C, Hine, P, Prudon, B, George, T, Wight, A, Baillie, JK, Basnyat, B, Buch, MH, Chappell, LC, Day, JN, Faust, SN, Hamers, RL, Jaki, T, Juszczak, E, Jeffery, K, Lim, WS, Montgomery, A, Mumford, A, Rowan, K, Thwaites, G, Mafham, M, Haynes, R, Landray, MJ

Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia: the ARREST RCT by Thwaites, GE, Scarborough, M, Szubert, AJ, Concalves, P, Soares, M, Bostock, J, Nsutebu, E, Tilley, R, Cunningham, R, Grieg, J, Wyllie, SA, Wilson, P, Auckland, C, Cairns, J, Ward, D, Lal, P, Guleri, A, Jenkins, N, Sutton, J, Wiselka, M, Armando, G-R, Graham, C, Chadwick, PR, Barlow, G, Gordon, C, Young, B, Meisner, S, McWhinney, P, Price, DA, Harvey, D, Nayar, D, Jeyaratnam, D, Planche, T, Minton, J, Hudson, F, Hopkins, S, Williams, J, Torok, EM, Llewelyn, MJ, Edgeworth, JD, Walker, AS